Profound Medical (CVE:PRN) had its target price raised by investment analysts at Paradigm Capital from C$2.25 to C$3.00 in a note issued to investors on Wednesday. The brokerage presently has a “buy” rating on the stock. Paradigm Capital’s target price indicates a potential upside of 209.28% from the company’s previous close.
PRN stock opened at C$0.97 on Wednesday. The firm has a market capitalization of $80.43 and a PE ratio of 2.85. Profound Medical has a one year low of C$0.61 and a one year high of C$1.19.
COPYRIGHT VIOLATION NOTICE: “Profound Medical (PRN) PT Raised to C$3.00 at Paradigm Capital” was reported by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3290522/profound-medical-prn-pt-raised-to-c3-00-at-paradigm-capital.html.
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.